Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC).

[1]  T. Okanoue,et al.  Circulating HCV-RNA, HCV genotype, and liver histology in asymptomatic individuals reactive for anti-HCV antibody and their follow-up study. , 2008, Liver.

[2]  P. Marcellin,et al.  Prospective study on anti‐hepatitis C virus–positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA , 2001, Hepatology.

[3]  F. Montagnese,et al.  Hepatitis C virus carriers with persistently normal aminotransferase levels: healthy people or true patients? , 2000, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[4]  N. Caporaso,et al.  Subjects positive for hepatitis C virus RNA with normal aminotransferase levels, a "trompe l'oeil" clinical picture? , 2000, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[5]  J. Albrecht,et al.  The significance of baseline serum alanine aminotransferase on pretreatment disease characteristics and response to antiviral therapy in chronic hepatitis C , 2000, Hepatology.

[6]  R. Torella,et al.  Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels. , 2000, Gastroenterology.

[7]  P. Marcellin,et al.  Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. , 2000, Journal of hepatology.

[8]  Sanjeev Arora,et al.  Clinical features of hepatitis C–infected patients with persistently normal alanine transaminase levels in the southwestern United States , 1999, Hepatology.

[9]  A. Magrini,et al.  Serum HCV RNA titer does not predict the severity of liver damage in HCV carriers with normal aminotransferase levels. , 1999, Liver.

[10]  J. Delattre,et al.  Factors associated with serum alanine transaminase activity in healthy subjects: Consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C , 1998, Hepatology.

[11]  M. Vidaud,et al.  Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity , 1998, Hepatology.

[12]  P. Marcellin,et al.  Therapy of hepatitis C: Patients with normal aminotransferase levels , 1997, Hepatology.

[13]  A. Magrini,et al.  Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels , 1997, Hepatology.

[14]  A. Magrini,et al.  Liver histology in anti-HCV positive subjects with normal ALT levels. , 1997, Italian journal of gastroenterology and hepatology.

[15]  A. Magrini,et al.  Phylogenetic analysis of hepatitis C virus isolates: Correlation to viremia, liver function tests, and histology , 1997, Hepatology.

[16]  L. Bolondi,et al.  Possible mechanisms for changes of intrasplenic arterial impedance indices in portal hypertension , 1997, Hepatology.

[17]  A. Magrini,et al.  Interferon for hepatitis C , 1997, The Lancet.

[18]  P. Hayes,et al.  Assessment of liver histology in patients with hepatitis C and normal transaminase levels. , 1996, European journal of gastroenterology & hepatology.

[19]  P. Simmonds,et al.  Lack of association between type of hepatitis C virus, serum load and severity of liver disease , 1996, Journal of viral hepatitis.

[20]  G. Bishop,et al.  Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C , 1996, Hepatology.

[21]  H. Thomas,et al.  The management of chronic hepatitis C virus infection. , 1995, Gut.

[22]  H. Conjeevaram,et al.  Volunteer Blood Donors with Antibody to Hepatitis C Virus: Clinical, Biochemical, Virologic, and Histologic Features , 1995, Annals of Internal Medicine.

[23]  M. Shindo,et al.  The virological and histological states of anti‐hepatitis C virus–positive subjects with normal liver biochemical values , 1995, Hepatology.

[24]  R. Chapman,et al.  Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transaminases. , 1995, Gut.

[25]  J. Córdoba,et al.  Does the healthy hepatitis C virus carrier state really exist? an analysis using polymerase chain reaction , 1995, Hepatology.

[26]  K. Ishak,et al.  Histological grading and staging of chronic hepatitis. , 1995 .

[27]  C. Babbs,et al.  Hepatitis C-related chronic liver disease among asymptomatic blood donors in the north west of England. , 1995, The Journal of infection.

[28]  R. Poupon,et al.  Prevalence, severity, and risk factors of liver disease in blood donors positive in a second‐generation anti—hepatitis C virus screening test , 1995, Hepatology.

[29]  Paul Landais,et al.  Hepatitis C Virus Type 1b (II) Infection in France and Italy , 1995, Annals of Internal Medicine.

[30]  M. Mondelli,et al.  Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities , 1995, Hepatology.

[31]  J. Hoofnagle,et al.  Genotypic analysis of hepatitis C virus in American patients , 1994, Hepatology.

[32]  A. Magrini,et al.  Prevalence of anti‐hepatitis C virus antibodies among patients hospitalized in a medical unit , 1994 .

[33]  S. Maclennan,et al.  Follow up of blood donors positive for antibodies to hepatitis C virus , 1994, BMJ.

[34]  P. Simmonds,et al.  Chronic hepatitis in United Kingdom blood donors infected with hepatitis C virus , 1994, BMJ.

[35]  C. Seymour.  Asymptomatic infection with hepatitis C virus , 1994, BMJ.

[36]  N. Hayashi,et al.  HCV viraemia and liver injury in symptom-free blood donors , 1993, The Lancet.

[37]  A. Alberti,et al.  Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV , 1992, The Lancet.

[38]  J. Esteban,et al.  High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. , 1991, Annals of internal medicine.

[39]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[40]  Willis C. Maddrey,et al.  EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement. , 1999, Journal of hepatology.

[41]  J. Pawlotsky,et al.  Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity. , 1996, Gastroenterology.

[42]  M. Colombo,et al.  Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection. , 1996, Gastroenterology.

[43]  N. Caporaso,et al.  Hepatitis C virus RNA in serum and liver histology in asymptomatic anti-HCV positive subjects , 1995, Infection.